← Back to Clinical Trials
Recruiting NCT06155643

NCT06155643 EKO SENSORA: Detecting Clinically Significant Murmurs

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06155643
Status Recruiting
Phase
Sponsor Corewell Health South
Condition Heart Murmurs
Study Type INTERVENTIONAL
Enrollment 300 participants
Start Date 2023-10-26
Primary Completion 2026-07-26

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Eko Sensora

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 300 participants in total. It began in 2023-10-26 with a primary completion date of 2026-07-26.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Eko Artificial Intelligence (AI) has primarily been evaluated in the primary care setting. The digital stethoscope records a phonocardiogram of heart sounds of the patient and uses machine learning artificial intelligence to identify if there are abnormalities present (Eko Health, 2023). The Eko SENSORA will be tested in the emergency department. Chest pain, fatigue, shortness of breath and syncope are all symptoms that could indicate a cardiac dysfunction. The hypothesis is that this device will allow us increased ability to detect valvular heart disease that is clinically significant.

Eligibility Criteria

Inclusion Criteria: * Chief complaint of chest pain, shortness of breath, difficulty breathing, or syncope/near-syncope. * Patients with chief complaint of Weakness would be eligible if over the age of 50 and have a history of at least two of hypertension, BMI\>/= 30, diabetes, hyperlipidemia, atrial fibrillation, heart attack, stroke/Transient ischemic attack, prior cardiac surgery or angiography Exclusion Criteria: * Contact isolation patients * Pediatric patients under the age of 18

Contact & Investigator

Central Contact

Monique Luna, MS

✉ monique.allen@corewellhealth.org

📞 2699838679

Frequently Asked Questions

Who can join the NCT06155643 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Murmurs. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06155643 currently recruiting?

Yes, NCT06155643 is actively recruiting participants. Contact the research team at monique.allen@corewellhealth.org for enrollment information.

Where is the NCT06155643 trial being conducted?

This trial is being conducted at Saint Joseph, United States.

Who is sponsoring the NCT06155643 clinical trial?

NCT06155643 is sponsored by Corewell Health South. The trial plans to enroll 300 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology